Stock CBST THE CANNABIST COMPANY HOLDINGS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials The Cannabist Company Holdings Inc. NEO Exchange

Equities

CBST

CA13765Y1034

Healthcare Facilities & Services

End-of-day quote NEO Exchange
Other stock markets
 06:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
0.35 CAD -1.41% Intraday chart for The Cannabist Company Holdings Inc. -11.39% -40.68%
Apr. 26 The Cannabist Company Holdings Inc. and Airo Brands Continue Successful Partnership with Expansion into Pennsylvania and Virginia CI
Apr. 16 The Cannabist Company Holdings Inc. Announces Launch of Its Triple Seven Brand in New York and Florida CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 538.3 1,756 1,076 309.3 193.5 119.2 - -
Enterprise Value (EV) 1 497.1 1,991 1,415 828.4 704.1 593 592.8 119.2
P/E ratio -5.08 x -12.6 x -6.81 x -0.71 x -1.05 x -1.79 x -4.49 x -3.72 x
Yield - - - - - - - -
Capitalization / Revenue 6.95 x 9.78 x 2.27 x 0.6 x 0.38 x 0.23 x 0.2 x 0.17 x
EV / Revenue 6.42 x 11.1 x 2.99 x 1.62 x 1.38 x 1.13 x 1 x 0.17 x
EV / EBITDA -10.6 x -481 x 16.6 x 12.3 x 10.1 x 7.51 x 5.79 x 1.04 x
EV / FCF -3,623,172 x -23,283,429 x -11,990,866 x -4,498,794 x -282,193,733 x - 59,275,047 x -
FCF Yield -0% -0% -0% -0% -0% - 0% -
Price to Book - 4.9 x 1.76 x - 2.81 x 2.17 x -13 x -1.86 x
Nbr of stocks (in thousands) 216,199 290,319 376,209 412,452 430,221 458,024 - -
Reference price 2 2.490 6.050 2.860 0.7500 0.4498 0.2601 0.2601 0.2601
Announcement Date 3/10/20 3/3/21 3/14/22 3/29/23 3/13/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 77.46 179.5 473.8 511.6 511.3 525.5 594.6 689.7
EBITDA 1 -46.94 -4.138 85.07 67.38 69.64 78.97 102.3 114.2
EBIT 1 -92.89 -74.1 -110.4 -113.5 -105.2 9.637 68.73 59.9
Operating Margin -119.92% -41.28% -23.29% -22.18% -20.58% 1.83% 11.56% 8.68%
Earnings before Tax (EBT) 1 - -136.9 -146.7 -432.7 -168.9 -10.9 32.08 28.6
Net income 1 -102.6 -110.8 -143.1 -416 -175.7 -104.6 10.87 21
Net margin -132.44% -61.71% -30.2% -81.32% -34.36% -19.91% 1.83% 3.04%
EPS 2 -0.4900 -0.4800 -0.4200 -1.060 -0.4300 -0.1451 -0.0580 -0.0700
Free Cash Flow -137.2 -85.49 -118 -184.1 -2.495 - 10 -
FCF margin -177.11% -47.63% -24.91% -35.99% -0.49% - 1.68% -
FCF Conversion (EBITDA) - - - - - - 9.77% -
FCF Conversion (Net income) - - - - - - 91.96% -
Dividend per Share - - - - - - - -
Announcement Date 3/10/20 3/3/21 3/14/22 3/29/23 3/13/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 132.3 139.3 123.1 129.6 132.7 126.2 124.5 129.2 129.2 128.4 126.7 128.7 131.4 135.5
EBITDA 1 31.02 27.21 16.83 12.03 20.99 17.4 16.36 20.32 20.49 12.47 15.4 18.46 20.38 22.78
EBIT 1 10.79 -84.84 -14.66 -22.11 -18.71 -58 -8.269 0.049 -19.33 -77.69 -1.51 1.157 3.733 6.232
Operating Margin 8.16% -60.92% -11.91% -17.06% -14.1% -45.96% -6.64% 0.04% -14.96% -60.52% -1.19% 0.9% 2.84% 4.6%
Earnings before Tax (EBT) 1 -49.34 -53.89 -27.27 -35.55 -31.73 -338.1 -25.88 -22.73 -33.88 -86.4 -13.8 -11.15 -8.507 -6.033
Net income 1 -36.18 -53.28 -26.64 -53.83 -35.43 -300.1 -37.34 -28.86 -36.72 -72.78 -29.38 -26.81 -25.11 -23.36
Net margin -27.35% -38.25% -21.64% -41.54% -26.69% -237.83% -29.98% -22.33% -28.43% -56.7% -23.19% -20.83% -19.11% -17.24%
EPS 2 -0.1100 -0.1400 -0.0700 -0.1400 -0.0900 -0.7500 -0.0900 -0.0700 -0.0900 -0.1800 -0.0562 -0.0600 -0.0540 -0.0504
Dividend per Share - - - - - - - - - - - - - -
Announcement Date 11/12/21 3/14/22 5/16/22 8/15/22 11/14/22 3/29/23 5/15/23 8/14/23 11/14/23 3/13/24 - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - 234 339 519 511 474 474 -
Net Cash position 1 41.3 - - - - - - -
Leverage (Debt/EBITDA) - -56.57 x 3.987 x 7.704 x 7.331 x 5.999 x 4.627 x -
Free Cash Flow -137 -85.5 -118 -184 -2.5 - 10 -
ROE (net income / shareholders' equity) -43.6% -25.3% -32.6% -30.9% - -5.3% - -
ROA (Net income/ Total Assets) -32.3% -12.7% -13.6% - - - - -
Assets 1 318.1 873.3 1,052 - - - - -
Book Value Per Share 2 - 1.240 1.630 - 0.1600 0.1200 -0.0200 -0.1400
Cash Flow per Share 2 -0.2800 -0.1800 - - - 0.0700 0.1000 -
Capex 1 77.4 42.9 118 72.7 9.97 24 11.4 10
Capex / Sales 99.98% 23.89% 24.8% 14.22% 1.95% 4.57% 1.92% 1.45%
Announcement Date 3/10/20 3/3/21 3/14/22 3/29/23 3/13/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Ratings for The Cannabist Company Holdings Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
0.2601 USD
Average target price
1.038 USD
Spread / Average Target
+299.02%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Farming

1st Jan change Capi.
ASCEND WELLNESS HOLDINGS, INC. Stock Ascend Wellness Holdings, Inc.
+31.96% 272M
AYR WELLNESS INC. Stock Ayr Wellness Inc.
+33.74% 261M
ORGANIGRAM HOLDINGS INC. Stock Organigram Holdings Inc.
+49.42% 194M
JUSHI HOLDINGS INC. Stock Jushi Holdings Inc.
+44.98% 131M
IANTHUS CAPITAL HOLDINGS, INC. Stock iAnthus Capital Holdings, Inc.
-28.57% 121M
INTERCURE LTD. Stock InterCure Ltd.
+115.91% 119M
4FRONT VENTURES CORP. Stock 4Front Ventures Corp.
0.00% 86.82M
BAKHU HOLDINGS, CORP. Stock Bakhu Holdings, Corp.
+150.00% 75.33M
CANNARA BIOTECH INC. Stock Cannara Biotech Inc.
+1.20% 55.24M
Medical Farming
  1. Stock Market
  2. Equities
  3. CBSTF Stock
  4. CBST Stock
  5. Financials The Cannabist Company Holdings Inc.